Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Roche Holding

Roche Holding reported 27.24B in Current Liabilities for its fiscal semester ending in December of 2022.

Current Liabilities Change
Alcon AG ALC:SW USD 2.6B 185M
Almirall SA ALM:SM EUR 274.61M 30.21M
Amgen AMGN:US USD 14.22B 1.47B
Artemis Alpha ATS:LN GBP 7.42M 2.04M
AstraZeneca AZN:LN USD 24.86B 1.43B
Bayer BAYN:GR EUR 34.39B 693M
Biogen BIIB:US USD 3.01B 257.9M
Eli Lilly LLY:US USD 16.01B 1.13B
Galapagos GLPG:NA EUR 522.9M 366K
Genmab GEN:DC DKK 1.96B 132M
Gilead Sciences GILD:US USD 10.53B 709M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
Hikma Pharmaceutical HIK:LN USD 1.08B 67M
Lonza Group LONN:SW CHF 3.08B 454M
Merck MRK:GR EUR 9.56B 43M
Novartis NOVN:VX USD 30.55B 1.89B
Orion ORNBV:FH EUR 252.4M 23M
Recordati REC:IM EUR 880.96M 42.78M
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Roche Holding ROG:VX 27.24B 170M
UCB UCB:BB 3.11B 216M